{"id":"https://openalex.org/W2071023751","doi":"https://doi.org/10.1592/phco.22.1.6.33495","title":"Dose Proportionality of Three Different Doses of Tibolone","display_name":"Dose Proportionality of Three Different Doses of Tibolone","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2071023751","doi":"https://doi.org/10.1592/phco.22.1.6.33495","mag":"2071023751","pmid":"https://pubmed.ncbi.nlm.nih.gov/11794431"},"language":"en","primary_location":{"id":"doi:10.1592/phco.22.1.6.33495","doi":"https://doi.org/10.1592/phco.22.1.6.33495","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.22.1.6.33495","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112724965","display_name":"Cees J. Timmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Cees J. Timmer","raw_affiliation_strings":["Department of Drug Metabolism and Kinetics, N.V. Organon, Oss, The Netherlands. cees.timmer@organon.com","Department of Drug Metabolism and Kinetics, N.V. Organon, Oss, The Netherlands (both authors)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Kinetics, N.V. Organon, Oss, The Netherlands. cees.timmer@organon.com","institution_ids":["https://openalex.org/I4405279838"]},{"raw_affiliation_string":"Department of Drug Metabolism and Kinetics, N.V. Organon, Oss, The Netherlands (both authors)","institution_ids":["https://openalex.org/I4405279838"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110827590","display_name":"Natalie S. Houwing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279838","display_name":"Organon (Netherlands)","ror":"https://ror.org/02388np20","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405279838"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Natalie S. Houwing","raw_affiliation_strings":["Department of Drug Metabolism and Kinetics, N.V. Organon, Oss, The Netherlands (both authors)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Kinetics, N.V. Organon, Oss, The Netherlands (both authors)","institution_ids":["https://openalex.org/I4405279838"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112724965"],"corresponding_institution_ids":["https://openalex.org/I4405279838"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.0959,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.79466759,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"22","issue":"1","first_page":"6","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tibolone","display_name":"tibolone","score":1.0},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.7409999966621399},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7200000286102295},{"id":"https://openalex.org/keywords/metabolites","display_name":"metabolites","score":0.7590000033378601},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.8190000057220459},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.9409999847412109},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.5210000276565552},{"id":"https://openalex.org/keywords/steady-state-plasma-concentration","display_name":"steady-state plasma concentration","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C2777457466","wikidata":"https://www.wikidata.org/wiki/Q413805","display_name":"Tibolone","level":3,"score":0.9789518117904663},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.8746870756149292},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6268228888511658},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6157069802284241},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5789259672164917},{"id":"https://openalex.org/C3019361228","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral dose","level":3,"score":0.5215237736701965},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.42448094487190247},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.42085015773773193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37102824449539185},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34532320499420166},{"id":"https://openalex.org/C3018603563","wikidata":"https://www.wikidata.org/wiki/Q177708","display_name":"Postmenopausal women","level":2,"score":0.16278564929962158},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009426","descriptor_name":"Netherlands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009652","descriptor_name":"Norpregnenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009652","descriptor_name":"Norpregnenes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009652","descriptor_name":"Norpregnenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020847","descriptor_name":"Estrogen Receptor Modulators","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020847","descriptor_name":"Estrogen Receptor Modulators","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020847","descriptor_name":"Estrogen Receptor Modulators","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1592/phco.22.1.6.33495","doi":"https://doi.org/10.1592/phco.22.1.6.33495","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.22.1.6.33495","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:11794431","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11794431","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1977960132","https://openalex.org/W1984386929","https://openalex.org/W1984955008","https://openalex.org/W1988870163","https://openalex.org/W1995656291","https://openalex.org/W2020796252","https://openalex.org/W2078098902","https://openalex.org/W2080639423","https://openalex.org/W2084746075","https://openalex.org/W2323444743","https://openalex.org/W2991671678"],"related_works":["https://openalex.org/W1521734316","https://openalex.org/W1984928719","https://openalex.org/W2321653293","https://openalex.org/W2031697458","https://openalex.org/W2131290368","https://openalex.org/W2111850022","https://openalex.org/W3145487580","https://openalex.org/W2063342912","https://openalex.org/W2074304951","https://openalex.org/W2084706508"],"abstract_inverted_index":{"STUDY":[0],"OBJECTIVE:":[1],"To":[2],"assess":[3],"dose":[4,118,142],"proportionality":[5],"of":[6,21,59,148],"tibolone":[7,43,60],"tablets":[8],"after":[9],"multiple":[10],"oral":[11],"administration.":[12],"DESIGN:":[13],"Open-label,":[14],"randomized,":[15],"three-period":[16],"crossover":[17],"study":[18],"SETTING:":[19],"Department":[20],"Drug":[22],"Metabolism":[23],"and":[24,61,89,100,123,134,143],"Kinetics,":[25],"N.V.":[26],"Organon,":[27],"Oss,":[28],"The":[29],"Netherlands.":[30],"SUBJECTS:":[31],"Twenty-seven":[32],"postmenopausal":[33],"women":[34],"aged":[35],"65":[36],"years":[37],"or":[38,46],"younger.":[39],"INTERVENTION:":[40],"Subjects":[41],"received":[42],"1.25,":[44],"2.5,":[45],"5.0":[47],"mg":[48],"once/day":[49],"for":[50,77,97,106,115,131],"7":[51],"days.":[52],"MEASUREMENTS":[53],"AND":[54],"MAIN":[55],"RESULTS:":[56],"Plasma":[57],"concentrations":[58],"its":[62],"three":[63],"primary":[64],"metabolites":[65],"were":[66,111],"assayed.":[67],"Steady":[68],"state":[69],"was":[70,79,129],"attained":[71],"by":[72],"day":[73],"5.":[74],"Elimination":[75],"half-life":[76],"3alpha-hydroxytibolone":[78],"7.2-8.5":[80],"hours.":[81],"At":[82],"steady":[83],"state,":[84],"the":[85,92,98,107,116,121,132,140,144],"dose-normalized":[86],"peak":[87],"concentration":[88],"area":[90],"under":[91],"curve":[93],"satisfied":[94],"bioequivalence":[95,128],"requirements":[96],"1.25-":[99,122,133],"2.5-mg":[101,124,135],"doses,":[102,136],"but":[103,137],"not":[104,138],"fully":[105],"5.0-mg":[108,117,141],"dose.":[109],"Parameters":[110],"proportionally":[112],"slightly":[113],"lower":[114,146],"compared":[119],"with":[120],"doses.":[125],"CONCLUSION:":[126],"Proportional":[127],"established":[130],"between":[139],"two":[145],"doses":[147],"tibolone.":[149]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}